These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 10734181

  • 21. Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase.
    Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):184-90. PubMed ID: 9655859
    [Abstract] [Full Text] [Related]

  • 22. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T, Melck D, Bobrov MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V.
    Biochem J; 2000 Nov 01; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [Abstract] [Full Text] [Related]

  • 23. Anandamide transport: a critical review.
    Glaser ST, Kaczocha M, Deutsch DG.
    Life Sci; 2005 Aug 19; 77(14):1584-604. PubMed ID: 15979096
    [Abstract] [Full Text] [Related]

  • 24. Organized trafficking of anandamide and related lipids.
    Yates ML, Barker EL.
    Vitam Horm; 2009 Aug 19; 81():25-53. PubMed ID: 19647107
    [Abstract] [Full Text] [Related]

  • 25. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):217-21. PubMed ID: 9070252
    [Abstract] [Full Text] [Related]

  • 26. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.
    Bisogno T, Delton-Vandenbroucke I, Milone A, Lagarde M, Di Marzo V.
    Arch Biochem Biophys; 1999 Oct 15; 370(2):300-7. PubMed ID: 10577359
    [Abstract] [Full Text] [Related]

  • 27. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.
    Jonsson KO, Andersson A, Jacobsson SO, Vandevoorde S, Lambert DM, Fowler CJ.
    Arch Toxicol; 2003 Apr 15; 77(4):201-7. PubMed ID: 12698235
    [Abstract] [Full Text] [Related]

  • 28. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):275-84. PubMed ID: 10448105
    [Abstract] [Full Text] [Related]

  • 29. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes.
    Hillard CJ, Jarrahian A.
    Chem Phys Lipids; 2000 Nov 19; 108(1-2):123-34. PubMed ID: 11106786
    [Abstract] [Full Text] [Related]

  • 30. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
    Kaczocha M, Hermann A, Glaser ST, Bojesen IN, Deutsch DG.
    J Biol Chem; 2006 Apr 07; 281(14):9066-75. PubMed ID: 16461355
    [Abstract] [Full Text] [Related]

  • 31. Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation.
    Fezza F, Oddi S, Di Tommaso M, De Simone C, Rapino C, Pasquariello N, Dainese E, Finazzi-Agrò A, Maccarrone M.
    J Lipid Res; 2008 Jun 07; 49(6):1216-23. PubMed ID: 18316795
    [Abstract] [Full Text] [Related]

  • 32. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.
    Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB.
    Mol Pharmacol; 1998 Jul 07; 54(1):180-8. PubMed ID: 9658204
    [Abstract] [Full Text] [Related]

  • 33. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.
    Rakhshan F, Day TA, Blakely RD, Barker EL.
    J Pharmacol Exp Ther; 2000 Mar 07; 292(3):960-7. PubMed ID: 10688610
    [Abstract] [Full Text] [Related]

  • 34. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons.
    Basavarajappa BS, Saito M, Cooper TB, Hungund BL.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):73-83. PubMed ID: 12679143
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, Felder CC.
    Mol Pharmacol; 1995 Aug 11; 48(2):288-92. PubMed ID: 7651362
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.
    Holt S, Fowler CJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar 11; 367(3):237-44. PubMed ID: 12644895
    [Abstract] [Full Text] [Related]

  • 40. Inhibitors of arachidonoyl ethanolamide hydrolysis.
    Koutek B, Prestwich GD, Howlett AC, Chin SA, Salehani D, Akhavan N, Deutsch DG.
    J Biol Chem; 1994 Sep 16; 269(37):22937-40. PubMed ID: 8083191
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.